198 related articles for article (PubMed ID: 2446801)
1. The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction.
Nattel S; Davies M; Quantz M
Circulation; 1988 Jan; 77(1):200-8. PubMed ID: 2446801
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion.
Somani P; Simon VA; McManus K
Can J Cardiol; 1985 Jan; 1(1):56-65. PubMed ID: 3850764
[TBL] [Abstract][Full Text] [Related]
3. Concentration response relationships of amiodarone and desethylamiodarone.
Connolly SJ; Gupta RN; Hoffert D; Roberts RS
Am Heart J; 1988 Jun; 115(6):1208-13. PubMed ID: 3376838
[TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic effects of desethylamiodarone in dogs with subacute myocardial infarction and inducible ventricular arrhythmias.
Abdollah H; Brien JF; Brennan FJ
J Cardiovasc Pharmacol; 1989 Jan; 13(1):37-44. PubMed ID: 2468934
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic effect of chronic oral amiodarone treatment in dogs with myocardial infarction and reproducibly inducible sustained ventricular arrhythmias.
Abdollah H; Brien JF; Brennan FJ
J Cardiovasc Pharmacol; 1990 May; 15(5):799-807. PubMed ID: 1692941
[TBL] [Abstract][Full Text] [Related]
6. Anti-arrhythmic effects of amiodarone and desethylamiodarone on malignant ventricular arrhythmias arising as a consequence of ischaemia and reperfusion in the anaesthetised rat.
Riva E; Hearse DJ
Cardiovasc Res; 1989 Apr; 23(4):331-9. PubMed ID: 2590914
[TBL] [Abstract][Full Text] [Related]
7. Comparative electrophysiologic effects of intravenous amiodarone and desethylamiodarone in dogs: evidence for clinically relevant activity of the metabolite.
Talajic M; DeRoode MR; Nattel S
Circulation; 1987 Jan; 75(1):265-71. PubMed ID: 3791608
[TBL] [Abstract][Full Text] [Related]
8. Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations.
Escoubet B; Coumel P; Poirier JM; Maison-Blanche P; Jaillon P; Leclercq JF; Menasche P; Cheymol G; Piwnica A; Lagier G
Am J Cardiol; 1985 Mar; 55(6):696-702. PubMed ID: 3976511
[TBL] [Abstract][Full Text] [Related]
9. Relationship between myocardial amiodarone concentration and antiarrhythmic effect in dogs with myocardial infarction and electrically induced ventricular arrhythmias.
Abdollah H; Brennan FJ; Jimmo S; Brien JF
Can J Physiol Pharmacol; 1991 Jun; 69(6):812-7. PubMed ID: 1913327
[TBL] [Abstract][Full Text] [Related]
10. Relationship of steady-state serum concentrations of amiodarone and desethylamiodarone to therapeutic efficacy and adverse effects.
Falik R; Flores BT; Shaw L; Gibson GA; Josephson ME; Marchlinski FE
Am J Med; 1987 Jun; 82(6):1102-8. PubMed ID: 3605129
[TBL] [Abstract][Full Text] [Related]
11. Long-term pretreatment with desethylamiodarone (DEA) or amiodarone (AMIO) protects against coronary artery occlusion induced ventricular arrhythmias in conscious rats.
Morvay N; Baczkó I; Sztojkov-Ivanov A; Falkay G; Papp JG; Varró A; Leprán I
Can J Physiol Pharmacol; 2015 Sep; 93(9):773-7. PubMed ID: 26176275
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic studies of amiodarone and its active N-desethyl metabolite.
Nattel S
J Cardiovasc Pharmacol; 1986; 8(4):771-7. PubMed ID: 2427817
[TBL] [Abstract][Full Text] [Related]
13. Antiarrhythmic properties of a prior oral loading of amiodarone in in vivo canine coronary ligation/reperfusion-induced arrhythmia model: comparison with other class III antiarrhythmic drugs.
Nagasawa Y; Chen J; Hashimoto K
J Pharmacol Sci; 2005 Mar; 97(3):393-9. PubMed ID: 15764841
[TBL] [Abstract][Full Text] [Related]
14. Amiodarone- and desethylamiodarone-induced myelinoid inclusion bodies and toxicity in cultured rat hepatocytes.
Somani P; Bandyopadhyay S; Klaunig JE; Gross SA
Hepatology; 1990 Jan; 11(1):81-92. PubMed ID: 2153095
[TBL] [Abstract][Full Text] [Related]
15. Distribution of amiodarone and desethylamiodarone in a patient with acute myocardial infarction after intravenous administration.
Barbieri E; Latini R; D'Aranno V; Fabbri A; Zampieri P; Trevi GP; Zardini P
Clin Cardiol; 1987 Nov; 10(11):674-6. PubMed ID: 3677501
[TBL] [Abstract][Full Text] [Related]
16. Disposition of amiodarone and its proximate metabolite, desethylamiodarone, in the dog for oral administration of single-dose and short-term drug regimens.
Brien JF; Jimmo S; Brennan FJ; Armstrong PW; Abdollah H
Drug Metab Dispos; 1990; 18(6):846-51. PubMed ID: 1981527
[TBL] [Abstract][Full Text] [Related]
17. [Control of anti-arrhythmia therapy with amiodarone. Value of the determination of blood levels].
Nitsch J; Lüderitz B
Dtsch Med Wochenschr; 1984 Mar; 109(13):492-5. PubMed ID: 6423357
[TBL] [Abstract][Full Text] [Related]
18. Myocardial amiodarone concentrations after short- and long-term treatment in patients with end-stage heart failure.
Candinas R; Frielingsdorf J; Ha HR; Carrel T; Turina M; Follath F
Eur J Clin Pharmacol; 1998 Jan; 53(5):331-6. PubMed ID: 9516032
[TBL] [Abstract][Full Text] [Related]
19. Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity.
Rotmensch HH; Belhassen B; Swanson BN; Shoshani D; Spielman SR; Greenspon AJ; Greenspan AM; Vlasses PH; Horowitz LN
Ann Intern Med; 1984 Oct; 101(4):462-9. PubMed ID: 6476633
[TBL] [Abstract][Full Text] [Related]
20. [Plasma concentrations and amiodarone/desethylamiodarone relations in patients subjected to chronic treatment].
Ortiz M; Gaete L; Asenjo R; Fernández F; Saavedra I
Rev Med Chil; 1996 Jan; 124(1):77-82. PubMed ID: 8762622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
